Bacterial activation of human natural killer cells: role of cell surface lipopolysaccharide
Culture of human peripheral blood lymphocytes with gram-negative bacteria associated with periodontal disease caused a rapid increase in the cytotoxic potential of natural killer (NK) cells. The NK cells were activated to kill NK-resistant targets, the peak cytotoxicity occurring on day 1 of culture...
Uloženo v:
| Vydáno v: | Infection and immunity Ročník 56; číslo 5; s. 1301 |
|---|---|
| Hlavní autor: | |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.05.1988
|
| Témata: | |
| ISSN: | 0019-9567 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Culture of human peripheral blood lymphocytes with gram-negative bacteria associated with periodontal disease caused a rapid increase in the cytotoxic potential of natural killer (NK) cells. The NK cells were activated to kill NK-resistant targets, the peak cytotoxicity occurring on day 1 of culture. The addition of anti-Tac, anti-CD3, or anti-OKT-11 antibodies to block activation via the interleukin-2 (IL-2), T-cell, or E rosette receptors had a minimal effect on this inductive process. Anti-IL-2 antiserum was effective in blocking a significant amount, but not all, of the cytotoxicity in bacterium-activated cultures. Modest IL-2 production (5 to 6 National Institutes of Health units) was measured in lymphocyte cultures activated by bacteria, but proliferation was not induced during a 1-week period. When polymixin B sulfate was added to bind and block lipopolysaccharides, bacterium-induced cytotoxicity was completely abrogated for all activating bacteria. In addition, when culture supernatants from Actinobacillus actinomycetemcomitans were tested, activation still occurred. However, again, this activation was totally inhibited by polymixin B sulfate. Monocytes were also activated by bacteria to produce tumor necrosis factor (TNF). To exclude the possibility that TNF was responsible for cytotoxicity, an antiserum to TNF was added to cocultures of bacteria and lymphocytes with adherent cells removed. The antiserum had no effect on the inductive process. In addition, exogenous TNF did not kill M14 targets. These results suggest that bacterial cell surface lipopolysaccharides provide a major activation signal for NK cells to enhance cytotoxicity. |
|---|---|
| AbstractList | Culture of human peripheral blood lymphocytes with gram-negative bacteria associated with periodontal disease caused a rapid increase in the cytotoxic potential of natural killer (NK) cells. The NK cells were activated to kill NK-resistant targets, the peak cytotoxicity occurring on day 1 of culture. The addition of anti-Tac, anti-CD3, or anti-OKT-11 antibodies to block activation via the interleukin-2 (IL-2), T-cell, or E rosette receptors had a minimal effect on this inductive process. Anti-IL-2 antiserum was effective in blocking a significant amount, but not all, of the cytotoxicity in bacterium-activated cultures. Modest IL-2 production (5 to 6 National Institutes of Health units) was measured in lymphocyte cultures activated by bacteria, but proliferation was not induced during a 1-week period. When polymixin B sulfate was added to bind and block lipopolysaccharides, bacterium-induced cytotoxicity was completely abrogated for all activating bacteria. In addition, when culture supernatants from Actinobacillus actinomycetemcomitans were tested, activation still occurred. However, again, this activation was totally inhibited by polymixin B sulfate. Monocytes were also activated by bacteria to produce tumor necrosis factor (TNF). To exclude the possibility that TNF was responsible for cytotoxicity, an antiserum to TNF was added to cocultures of bacteria and lymphocytes with adherent cells removed. The antiserum had no effect on the inductive process. In addition, exogenous TNF did not kill M14 targets. These results suggest that bacterial cell surface lipopolysaccharides provide a major activation signal for NK cells to enhance cytotoxicity. Culture of human peripheral blood lymphocytes with gram-negative bacteria associated with periodontal disease caused a rapid increase in the cytotoxic potential of natural killer (NK) cells. The NK cells were activated to kill NK-resistant targets, the peak cytotoxicity occurring on day 1 of culture. The addition of anti-Tac, anti-CD3, or anti-OKT-11 antibodies to block activation via the interleukin-2 (IL-2), T-cell, or E rosette receptors had a minimal effect on this inductive process. Anti-IL-2 antiserum was effective in blocking a significant amount, but not all, of the cytotoxicity in bacterium-activated cultures. Modest IL-2 production (5 to 6 National Institutes of Health units) was measured in lymphocyte cultures activated by bacteria, but proliferation was not induced during a 1-week period. When polymixin B sulfate was added to bind and block lipopolysaccharides, bacterium-induced cytotoxicity was completely abrogated for all activating bacteria. In addition, when culture supernatants from Actinobacillus actinomycetemcomitans were tested, activation still occurred. However, again, this activation was totally inhibited by polymixin B sulfate. Monocytes were also activated by bacteria to produce tumor necrosis factor (TNF). To exclude the possibility that TNF was responsible for cytotoxicity, an antiserum to TNF was added to cocultures of bacteria and lymphocytes with adherent cells removed. The antiserum had no effect on the inductive process. In addition, exogenous TNF did not kill M14 targets. These results suggest that bacterial cell surface lipopolysaccharides provide a major activation signal for NK cells to enhance cytotoxicity.Culture of human peripheral blood lymphocytes with gram-negative bacteria associated with periodontal disease caused a rapid increase in the cytotoxic potential of natural killer (NK) cells. The NK cells were activated to kill NK-resistant targets, the peak cytotoxicity occurring on day 1 of culture. The addition of anti-Tac, anti-CD3, or anti-OKT-11 antibodies to block activation via the interleukin-2 (IL-2), T-cell, or E rosette receptors had a minimal effect on this inductive process. Anti-IL-2 antiserum was effective in blocking a significant amount, but not all, of the cytotoxicity in bacterium-activated cultures. Modest IL-2 production (5 to 6 National Institutes of Health units) was measured in lymphocyte cultures activated by bacteria, but proliferation was not induced during a 1-week period. When polymixin B sulfate was added to bind and block lipopolysaccharides, bacterium-induced cytotoxicity was completely abrogated for all activating bacteria. In addition, when culture supernatants from Actinobacillus actinomycetemcomitans were tested, activation still occurred. However, again, this activation was totally inhibited by polymixin B sulfate. Monocytes were also activated by bacteria to produce tumor necrosis factor (TNF). To exclude the possibility that TNF was responsible for cytotoxicity, an antiserum to TNF was added to cocultures of bacteria and lymphocytes with adherent cells removed. The antiserum had no effect on the inductive process. In addition, exogenous TNF did not kill M14 targets. These results suggest that bacterial cell surface lipopolysaccharides provide a major activation signal for NK cells to enhance cytotoxicity. |
| Author | Lindemann, R A |
| Author_xml | – sequence: 1 givenname: R A surname: Lindemann fullname: Lindemann, R A organization: UCLA School of Dentistry, Center for the Health Sciences 90024 |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/2895743$$D View this record in MEDLINE/PubMed |
| BookMark | eNotkEtPwzAQhH0oKm3hJyB84pYQO35yKxWPSpW4wIlDtHFtNeDEwU6Q-u9JRS-7O5pPq9Es0awLnUXolhQ5IVTdb9fbnIuc56QsSDYNlROt1AwtioLoTHMhL9Eypa9JMsbUHM2p0lyycoE-H8EMNjbg8XQ0vzA0ocPB4cPYQoc7GMY4ed-N9zZiY71PDzgGb0_MSeI0RgfGYt_0oQ_-mMCYA8Rmb6_QhQOf7PV5r9DH89P75jXbvb1sN-tdZpiWQyY4dVyDLkqgApgDB1P6kjtlSmYJlaWsqa2F5gUDUdvJkVbvgRhVi1o6ukJ3_3_7GH5Gm4aqbdIpG3Q2jKmSighGOJvAmzM41q3dV31sWojH6twG_QOMrWQJ |
| CitedBy_id | crossref_primary_10_33073_pjm_2021_043 crossref_primary_10_1111_j_1600_0765_1991_tb01646_x crossref_primary_10_1034_j_1600_0757_2001_2260104_x crossref_primary_10_1111_j_1600_0765_1995_tb02132_x crossref_primary_10_1111_j_1399_302X_1992_tb00515_x crossref_primary_10_1038_s41598_018_36070_3 crossref_primary_10_3390_ijms25158090 crossref_primary_10_1111_j_1399_302X_1994_tb00057_x crossref_primary_10_1111_j_1600_0765_1991_tb01799_x crossref_primary_10_1111_j_1600_051X_1996_tb01811_x crossref_primary_10_1128_IAI_67_1_201_205_1999 crossref_primary_10_3390_nu12092828 crossref_primary_10_1111_j_1600_0765_1989_tb00851_x crossref_primary_10_1111_j_1600_0765_1992_tb01814_x |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1128/IAI.56.5.1301-1308.1988 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine Biology |
| ExternalDocumentID | 2895743 |
| Genre | Journal Article |
| GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 18M 29I 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 85S AAGFI ABOCM ACGFO ADBBV ADXHL AENEX AGCDD AGVNZ AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CGR CS3 CUY CVF D0S DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 H13 HYE HZ~ H~9 IH2 J5H KQ8 L7B MVM NEJ NPM O9- OHT OK1 P2P RHI RNS RPM RSF SJN TR2 TWZ UPT VH1 W2D W8F WH7 WHG WOQ X7M Y6R ZGI ZXP ~KM 7X8 |
| ID | FETCH-LOGICAL-c497t-652f59a903a26a4fafa98835f8c34e12737b2eb69504a6be35f7e9da1c8b6b7f2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 47 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=10.1128/iai.56.5.1301-1308.1988&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0019-9567 |
| IngestDate | Thu Oct 02 06:46:36 EDT 2025 Tue Aug 05 11:36:39 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c497t-652f59a903a26a4fafa98835f8c34e12737b2eb69504a6be35f7e9da1c8b6b7f2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://iai.asm.org/content/iai/56/5/1301.full.pdf |
| PMID | 2895743 |
| PQID | 78164154 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_78164154 pubmed_primary_2895743 |
| PublicationCentury | 1900 |
| PublicationDate | 1988-05-01 |
| PublicationDateYYYYMMDD | 1988-05-01 |
| PublicationDate_xml | – month: 05 year: 1988 text: 1988-05-01 day: 01 |
| PublicationDecade | 1980 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Infection and immunity |
| PublicationTitleAlternate | Infect Immun |
| PublicationYear | 1988 |
| References | 3093576 - J Immunol. 1986 Oct 15;137(8):2428-33 3108384 - J Immunol. 1987 Jun 15;138(12):4185-91 7439996 - Infect Immun. 1980 Nov;30(2):588-600 6231105 - Cell. 1984 Apr;36(4):897-906 2440924 - J Dent Res. 1987 Mar;66(3):770-3 3489062 - J Exp Med. 1986 Sep 1;164(3):814-25 3928175 - Cell Immunol. 1985 Sep;94(2):568-78 3097225 - J Leukoc Biol. 1986 Dec;40(6):801-13 3108674 - Nature. 1987 Jun 11-17;327(6122):518-22 363939 - J Immunol. 1978 Dec;121(6):2160-4 6336774 - J Immunol. 1983 Feb;130(2):903-7 2419446 - J Immunol. 1986 Apr 1;136(7):2662-9 205612 - J Immunol. 1978 Apr;120(4):1415-22 7334070 - J Clin Immunol. 1981 Jan;1(1):51-63 6348161 - J Immunol Methods. 1983 Jul 29;61(3):293-300 3872989 - Microbiol Immunol. 1985;29(1):1-12 4374476 - J Infect Dis. 1974 Oct;130(4):384-7 187544 - Immunochemistry. 1976 Oct;13(10):813-8 6166701 - J Exp Med. 1981 Mar 1;153(3):569-82 309629 - Scand J Immunol. 1978;8(4):347-54 6685343 - Science. 1983 Nov 11;222(4624):581-5 4113792 - J Immunol. 1972 Jul;109(1):129-35 6183011 - Cell Immunol. 1982 Jul 15;71(1):66-79 6607107 - Cancer Res. 1984 Mar;44(3):1044-7 6176669 - J Exp Med. 1982 Jun 1;155(6):1823-41 761939 - Immunol Rev. 1979;44:43-70 6833762 - J Immunol. 1983 May;130(5):2479-83 785281 - Nature. 1976 Aug 12;262(5569):584-6 |
| References_xml | – reference: 6833762 - J Immunol. 1983 May;130(5):2479-83 – reference: 785281 - Nature. 1976 Aug 12;262(5569):584-6 – reference: 187544 - Immunochemistry. 1976 Oct;13(10):813-8 – reference: 6231105 - Cell. 1984 Apr;36(4):897-906 – reference: 6348161 - J Immunol Methods. 1983 Jul 29;61(3):293-300 – reference: 6183011 - Cell Immunol. 1982 Jul 15;71(1):66-79 – reference: 6336774 - J Immunol. 1983 Feb;130(2):903-7 – reference: 3489062 - J Exp Med. 1986 Sep 1;164(3):814-25 – reference: 2419446 - J Immunol. 1986 Apr 1;136(7):2662-9 – reference: 6607107 - Cancer Res. 1984 Mar;44(3):1044-7 – reference: 6176669 - J Exp Med. 1982 Jun 1;155(6):1823-41 – reference: 363939 - J Immunol. 1978 Dec;121(6):2160-4 – reference: 7334070 - J Clin Immunol. 1981 Jan;1(1):51-63 – reference: 309629 - Scand J Immunol. 1978;8(4):347-54 – reference: 3097225 - J Leukoc Biol. 1986 Dec;40(6):801-13 – reference: 2440924 - J Dent Res. 1987 Mar;66(3):770-3 – reference: 3108674 - Nature. 1987 Jun 11-17;327(6122):518-22 – reference: 6685343 - Science. 1983 Nov 11;222(4624):581-5 – reference: 6166701 - J Exp Med. 1981 Mar 1;153(3):569-82 – reference: 4113792 - J Immunol. 1972 Jul;109(1):129-35 – reference: 7439996 - Infect Immun. 1980 Nov;30(2):588-600 – reference: 761939 - Immunol Rev. 1979;44:43-70 – reference: 3928175 - Cell Immunol. 1985 Sep;94(2):568-78 – reference: 3872989 - Microbiol Immunol. 1985;29(1):1-12 – reference: 205612 - J Immunol. 1978 Apr;120(4):1415-22 – reference: 3093576 - J Immunol. 1986 Oct 15;137(8):2428-33 – reference: 4374476 - J Infect Dis. 1974 Oct;130(4):384-7 – reference: 3108384 - J Immunol. 1987 Jun 15;138(12):4185-91 |
| SSID | ssj0014448 |
| Score | 1.4782059 |
| Snippet | Culture of human peripheral blood lymphocytes with gram-negative bacteria associated with periodontal disease caused a rapid increase in the cytotoxic... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1301 |
| SubjectTerms | Antigens, Bacterial - immunology Carrier Proteins - immunology CD2 Antigens Cytotoxicity, Immunologic Gram-Negative Bacteria - immunology Humans Immunity, Cellular Immunity, Innate In Vitro Techniques Interleukin-2 - biosynthesis Killer Cells, Natural - immunology Lipopolysaccharides - immunology Lymphocyte Activation Monocytes - immunology Periodontal Diseases - immunology Receptors, Antigen, T-Cell - immunology Receptors, Immunologic - immunology Receptors, Immunologic - physiology Receptors, Interleukin-2 Tumor Necrosis Factor-alpha - biosynthesis |
| Title | Bacterial activation of human natural killer cells: role of cell surface lipopolysaccharide |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/2895743 https://www.proquest.com/docview/78164154 |
| Volume | 56 |
| WOSCitedRecordID | wos10.1128/iai.56.5.1301-1308.1988&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwED-mU_HFj-lwfubB126uTZpUBFFx-ODGHhQGPpRrlkBRurluwv57L22HT-KDL4GSFEJyufzucnc_gEsdWLI7SHgJ6guPazJ3kBvlJb6vhCQAq3Wx089yMFCjUTSswc0qF8aFVa50YqGoxxPtfOQdqQjY031_O_30HGeUe1utCDTWoB4QkHEyLUc_bwic80oPRx5ZAbKK7iKF3EkxbYuwLRwXctejRrXJ-Fa_o8zitunt_m-ee7BToUx2V4rFPtRM1oDNkndy2YCtfvWifgBv92W5ZhrtUhxKBy2bWFaQ97Gi7if1vRcpg8y5-fNr5kIS3Rj3yfLFzKI27COdOsKFZY7apXKlY3MIr73Hl4cnryJc8DSP5NwLhW9FhNFVgH6I3KJFWpVAWKUDbrqEdGTimySMxBXHMDHUI000xq5WSZhI6zdhPZtk5ghYwn3UXI-1IiFAl11L2CBCYTAwCQ-xBRer5YtJoN18MTOTRR6vFrAFzXIH4mlZdyMm21AQ4Dn-89cT2HbbWcYlnkLd0kk2Z7Chv-ZpPjsvxITawbD_DfE3xrs |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bacterial+activation+of+human+natural+killer+cells%3A+role+of+cell+surface+lipopolysaccharide&rft.jtitle=Infection+and+immunity&rft.au=Lindemann%2C+R+A&rft.date=1988-05-01&rft.issn=0019-9567&rft.volume=56&rft.issue=5&rft.spage=1301&rft_id=info:doi/10.1128%2FIAI.56.5.1301-1308.1988&rft_id=info%3Apmid%2F2895743&rft_id=info%3Apmid%2F2895743&rft.externalDocID=2895743 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0019-9567&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0019-9567&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0019-9567&client=summon |